SNORD27: A Protein Regulating Cell Cycle, Apoptosis and Inflammation

Target Name: SNORD27

NCBI ID: G9301

SNORD27

Other Name(s): RNU27 | small nucleolar RNA, C/D box 27 | Small nucleolar RNA, C/D box 27 | U27

SNORD27: A Protein Regulating Cell Cycle, Apoptosis and Inflammation

SNORD27 (RNU27) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a key regulator of the cell cycle, and its levels have been linked to the development and progression of various diseases , including cancer. As a result, SNORD27 has become a focus of interest in the search for new treatments.

One of the key features of SNORD27 is its role in regulating the cell cycle. The cell cycle is the process by which a cell grows and replicates its genetic material. SNORD27 is involved in the regulation of the G1 phase of the cell cycle, which is the phase when the cell prepares for growth and division.

SNORD27 has been shown to play a key role in regulating the length of the G1 phase. In studies using cell culture models, researchers have found that SNORD27 helps to shorten the G1 phase by preventing the accumulation of excessively long replication complexes. This is important for ensuring that the cell has enough time to complete its necessary preparations before entering the S phase, where the cell divides and creates new genetic material.

Another important function of SNORD27 is its role in the regulation of apoptosis, or programmed cell death. Apoptosis is a natural process that helps the body to remove damaged or dysfunctional cells. SNORD27 has been shown to play a key role in the regulation of apoptosis, by ensuring that the cell undergoes the necessary steps before undergoing apoptosis.

In addition to its role in regulating the cell cycle and apoptosis, SNORD27 has also been shown to be involved in the regulation of inflammation. Inflammation is a natural response of the immune system, but when it becomes chronic or uncontrolled, it can lead to a range of diseases, including cancer. SNORD27 has been shown to play a key role in the regulation of inflammation, by ensuring that it is properly controlled and does not contribute to the development of chronic inflammatory diseases.

SNORD27 is also a potential drug target, as it has been shown to play a key role in a variety of diseases, including cancer. For example, studies have found that high levels of SNORD27 are associated with poor prognosis in patients with pancreatic cancer, a type of cancer that is often deadly. Additionally, SNORD27 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's.

In conclusion, SNORD27 is a protein that plays a critical role in the regulation of the cell cycle, apoptosis, and inflammation. Its levels have been linked to the development and progression of various diseases, including cancer. As a result, SNORD27 has become a focus of interest in the search for new treatments. Further research is needed to fully understand the role of SNORD27 in these processes, and to determine its potential as a drug target.

Protein Name: Small Nucleolar RNA, C/D Box 27

The "SNORD27 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD27 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets